Work

Re: Cabazitaxel versus Docetaxel as First-Line Therapy for Patients with Metastatic Castration-Resistant Prostate Cancer: A Randomized Phase III Trial—FIRSTANA

Year: 2018

Type: letter

Source: The Journal of Urology

DOI: 10.1016/j.juro.2018.01.031

Author: Samir S. Taneja

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2783535867

Cites: 2

Cited by: 1

Related to: 10